Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription

被引:29
|
作者
Kumari, Daman [1 ]
Usdin, Karen [1 ]
机构
[1] Natl Inst Diabet Digest & Kidney Dis, Sect Gene Struct & Dis, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
DNA METHYLATION; HISTONE MODIFICATIONS; CELL SIGNATURE; MESSENGER-RNA; CGG REPEAT; STEM-CELLS; GENE; HYPERMETHYLATION; DEMETHYLATION; INSTABILITY;
D O I
10.1093/hmg/ddu378
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The FMR1 geneis subject to repeat mediated-gene silencingwhentheCGG-repeat tract in the 5' UTR exceeds 200 repeat units. This results in Fragile X syndrome, the most common heritable cause of intellectual disability and a major cause of autism spectrum disorders. The mechanism of gene silencing is not fully understood, and efforts to reverse this gene silencing have had limited success. Here, we show that the level of trimethylation of histone H3 on lysine 27, a hallmark of the activity of EZH2, a component of repressive Polycomb Group (PcG) complexes like PRC2, is increased on reactivation of the silenced allele by either the DNA demethylating agent 5-azadeoxycytidine or the SIRT1 inhibitor splitomicin. The level of H3K27me3 increases and decreases in parallel with the FMR1 mRNA level. Furthermore, reducing the levels of the FMR1 mRNA reduces the accumulation of H3K27me3. This suggests a model for FMR1 gene silencing in which the FMR1 mRNA generated from the reactivated allele acts in cis to repress its own transcription via the recruitment of PcG complexes to the FMR1 locus.
引用
收藏
页码:6575 / 6583
页数:9
相关论文
共 50 条
  • [1] Transcription of the FMR1 gene in individuals with fragile X syndrome
    Tassone, F
    Hagerman, RJ
    Chamberlain, WD
    Hagerman, PJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 97 (03): : 195 - 203
  • [2] FMR1 gene and fragile X syndrome
    Bardoni, B
    Mandel, JL
    Fisch, GS
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 97 (02): : 153 - 163
  • [3] Fragile X syndrome with FMR1 and FMR2 deletion
    Moore, SJ
    Strain, L
    Cole, GF
    Miedzybrodzka, Z
    Kelly, KF
    Dean, JCS
    JOURNAL OF MEDICAL GENETICS, 1999, 36 (07) : 565 - 566
  • [4] Detection of the fragile X syndrome protein for the evaluation of FMR1 intermediate alleles
    Sergi Castellví-Bel
    Miguel Fernández-Burriel
    Maria Rifé
    Dolores Jiménez
    Judith Mallolas
    Aurora Sánchez
    Feliciano Ramos
    Montserrat Milà
    Human Genetics, 2000, 107 : 195 - 196
  • [5] Detection of the fragile X syndrome protein for the evaluation of FMR1 intermediate alleles
    Castellví-Bel, S
    Fernández-Burriel, M
    Rifé, M
    Jiménez, D
    Mallolas, J
    Sánchez, A
    Ramos, F
    Milà, M
    HUMAN GENETICS, 2000, 107 (02) : 195 - 196
  • [6] Fragile X syndrome and FMR1 associated disorders
    Tassone, F.
    FEBS JOURNAL, 2012, 279 : 38 - 38
  • [7] Finding FMR1 mosaicism in Fragile X syndrome
    Goncalves, Thais Fernandez
    dos Santos, Jussara Mendonca
    Goncalves, Andressa Pereira
    Tassone, Flora
    Mendoza-Morales, Guadalupe
    Ribeiro, Marcia Goncalves
    Kahn, Evelyn
    Boy, Raquel
    Goncalves Pimentel, Marcia Mattos
    Santos-Reboucas, Cintia Barros
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (04) : 501 - 507
  • [8] Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles
    Wang, Jun Yi
    Hessl, David
    Iwahashi, Christine
    Cheung, Katherine
    Schneider, Andrea
    Hagerman, Randi J.
    Hagerman, Paul J.
    Rivera, Susan M.
    NEUROIMAGE, 2013, 65 : 288 - 298
  • [9] PRECISION FMR1 METHYLATION ASSAY IN FRAGILE X SYNDROME
    Erickson, Craig
    Schmitt, Lauren
    Pilito, Sebastian
    Cullion, Kyle
    Horn, Paul
    Shanahan, Matilyn
    Gross, Christina
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 325 - 325
  • [10] Molecular analysis of FMR1 alleles for fragile X syndrome diagnosis and patient stratification
    Kumari, Daman
    Usdin, Karen
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (04) : 363 - 365